KIADIS BV and NV ORGANON enter into a discovery collaboration
30-May-2005
Under the terms of the collaboration, Organon will supply Kiadis with a proprietary target. Financial details of the collaboration are not disclosed. Kiadis will deliver Organon with novel active compounds against the target utilizing its BioSelact(TM) technology. Organon is particularly interested in the ability of Kiadis' BioSelact(tm) technology to efficiently characterize bioactive compounds present in complex chemical mixtures.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.